Laura A. Garvican, David T. Martin, Sally A. Clark, Walter F. Schmidt, and Christopher J. Gore
Philo U. Saunders, Laura A. Garvican-Lewis, Robert F. Chapman, and Julien D. Périard
High-level athletes are always looking at ways to maximize training adaptations for competition performance, and using altered environmental conditions to achieve this outcome has become increasingly popular by elite athletes. Furthermore, a series of potential nutrition and hydration interventions may also optimize the adaptation to altered environments. Altitude training was first used to prepare for competition at altitude, and it still is today; however, more often now, elite athletes embark on a series of altitude training camps to try to improve sea-level performance. Similarly, the use of heat acclimation/acclimatization to optimize performance in hot/humid environmental conditions is a common practice by high-level athletes and is well supported in the scientific literature. More recently, the use of heat training to improve exercise capacity in temperate environments has been investigated and appears to have positive outcomes. This consensus statement will detail the use of both heat and altitude training interventions to optimize performance capacities in elite athletes in both normal environmental conditions and extreme conditions (hot and/or high), with a focus on the importance of nutritional strategies required in these extreme environmental conditions to maximize adaptations conducive to competitive performance enhancement.
Laura A. Garvican, Kristal Hammond, Matthew C. Varley, Christopher J. Gore, Francois Billaut, and Robert J. Aughey
This study investigated the decrement in running performance of elite soccer players competing at low altitude and time course for abatement of these decrements.
Twenty elite youth soccer players had their activity profile, in a sea-level (SL) and 2 altitude (Alt, 1600 m, d 4, and d 6) matches, measured with a global positioning system. Measures expressed in meters per minute of match time were total distance, low- and high-velocity running (LoVR, 0.01–4.16 m/s; HiVR, 4.17–10.0 m/s), and frequency of maximal accelerations (>2.78 m/s2). The peak and subsequent stanza for each measure were identified and a transient fatigue index calculated. Mean heart rate (HR) during the final minute of a submaximal running task (5 min, 11 km/h) was recorded at SL and for 10 d at Alt. Differences were determined between SL and Alt using percentage change and effect-size (ES) statistic with 90% confidence intervals.
Mean HR almost certainly increased on d 1 (5.4%, ES 1.01 ± 0.35) and remained probably elevated on both d 2 (ES 0.42 ± 0.31) and d3 (ES 0.30 ± 0.25), returning to baseline at d 5. Total distance was almost certainly lower than SL (ES –0.76 ± 0.37) at d 4 and remained probably reduced on d 6 (ES –0.42 ± 0.36). HiVR probably decreased at d 4 vs SL (–0.47 ± 0.59), with no clear effect of altitude at d 6 (–0.08 ± 0.41). Transient fatigue in matches was evident at SL and Alt, with a possibly greater decrement at Alt.
Despite some physiological adaptation, match running performance of youth soccer players is compromised for at least 6 d at low altitude.
Laura A. Garvican, Louisa Lobigs, Richard Telford, Kieran Fallon, and Christopher J. Gore
Haemoglobin mass in a female endurance athlete was measured via carbon monoxide rebreathing upon diagnosis of iron-deficiency anemia (haemoglobin concentration = 8.8 g/dL, ferritin = 9.9 ng/mL) and regularly during treatment thereafter. Haemoglobin mass increased by 49% in the 2 wk following an intramuscular iron injection and continued to increase with oral iron supplementation for 15 wk. The presented case illustrates that haemoglobin mass is readily responsive to iron supplementation in a severely iron-defcient anemic athlete and that changes can be tracked efficiently using the CO-rebreathing method.
Amy L. Woods, Laura A. Garvican-Lewis, Anthony J. Rice, and Kevin G. Thompson
The aim of the current study was to determine if a single ParvoMedics TrueOne 2400 metabolic cart provides valid and reliable measurement of RMR in comparison with the criterion Douglas Bag method (DB). Ten endurance-trained participants completed duplicate RMR measurements on 2 consecutive days using the ParvoMedics system in exercise mode, with the same expirate analyzed using DB. Typical error (TE) in mean RMR between the systems was 578.9 kJ or 7.5% (p = .01). In comparison with DB, the ParvoMedics system over-estimated RMR by 946.7 ± 818.6 kJ. The bias between systems resulted from ParvoMedics VE(STPD) values. A regression equation was developed to correct the bias, which reduced the difference to -83.3 ± 631.9 kJ. TE for the corrected ParvoMedics data were 446.8 kJ or 7.2% (p = .70). On Day 1, intraday reliability in mean RMR for DB was 286.8 kJ or 4.3%, (p = .54) and for ParvoMedicsuncorrected, 359.3 kJ or 4.4%, (p = .35), with closer agreement observed on Day 2. Interday reliability for DB was 455.3 kJ or 6.6% (p = .61) and for ParvoMedicsuncorrected, 390.2 kJ or 6.3% (p = .54). Similar intraday and interday TE was observed between ParvoMedicsuncorrected and ParvoMedicscorrected data. The ParvoMedics TrueOne 2400 provided valid and reliable RMR values compared with DB when the VE(STPD) error was corrected. This will enable widespread monitoring of RMR using the ParvoMedics system in a range of field-based settings when DB is not available.
Amelia J. Carr, Philo U. Saunders, Laura A. Garvican-Lewis, and Brent S. Vallance
Purpose: To quantify, for an elite-level racewalker, altitude training, heat acclimation and acclimatization, physiological data, and race performance from January 2007 to August 2008. Methods: The participant performed 7 blocks of altitude training: 2 “live high:train high” blocks at 1380 m (total = 22 d) and 5 simulated “live high:train low” blocks at 3000 m/600 m (total = 98 d). Prior to the 2007 World Championships and the 2008 Olympic Games, 2 heat-acclimation blocks of ~6 weeks were performed (1 session/week), with ∼2 weeks of heat acclimatization completed immediately prior to each 20-km event. Results: During the observation period, physiological testing included maximal oxygen uptake (VO2max, mL·kg−1·min−1), walking speed (km·h−1) at 4 mmol·L−1 blood lactate concentration [La−], body mass (kg), and hemoglobin mass (g), and 12 × 20-km races and 2 × 50-km races were performed. The highest VO2max was 67.0 mL·kg−1·min−1 (August 2007), which improved 3.1% from the first measurement (64.9 mL·kg−1·min−1, June 2007). The highest percentage change in any physiological variable was 7.1%, for 4 mmol·L−1 [La−] walking speed, improving from 14.1 (June 2007) to 15.1 km·h−1 (August 2007). Personal-best times for 20 km improved from (hh:mm:ss) 1:21:36 to 1:19:41 (2.4%) and from 3:55:08 to 3:39:27 (7.1%) in the 50-km event. The participant won Olympic bronze and silver medals in the 20- and 50-km, respectively. Conclusions: Elite racewalkers who regularly perform altitude training may benefit from periodized heat acclimation and acclimatization prior to major international competitions in the heat.
Alice M. Wallett, Amy L. Woods, Nathan Versey, Laura A. Garvican-Lewis, Marijke Welvaert, and Kevin G. Thompson
Studies examining pacing strategies during 4000-m cycling time trials (TTs) typically ensure that participants are not prefatigued; however, competitive cyclists often undertake TTs when already fatigued. This study aimed to determine how TT pacing strategies and sprint characteristics of cyclists change during an intensified training period (mesocycle). Thirteen cyclists regularly competing in A- and B-grade cycling races and consistently training (>10 h/wk for 4  y) completed a 6-wk training mesocycle. Participants undertook individually prescribed training, using training stress scores (TrainingPeaks, Boulder, CO), partitioned into a baseline week, a build week, 2 loading weeks (designed to elicit an overreached state), and 2 recovery weeks. Laboratory-based tests (15-s sprint and TT) and Recovery-Stress Questionnaire (RESTQ-52) responses were repeatedly undertaken over the mesocycle. TT power output increased during recovery compared with baseline and loading weeks (P = .001) with >6-W increases in mean power output (MPO) detected for 400-m sections (10% bins) from 1200 to 4000 m in recovery weeks. Decreases in peak heart rate (P < .001) during loading weeks and postexercise blood lactate (P = .005) during loading week 2 and recovery week 1 were detected. Compared with baseline, 15-s sprint MPO declined during loading and recovery weeks (P < .001). An interaction was observed between RESTQ-52 total stress score with a 15-s sprint (P = .003) and with a TT MPO (P = .04), indicating that participants who experienced greater stress during loading weeks exhibited reduced performance. To conclude, intensified endurance training diminished sprint performance but improved 4000-m TT performance, with a subtle change in MPO evident over the last 70% of TTs.
Torben Pottgiesser, Laura A. Garvican, David T. Martin, Jesse M. Featonby, Christopher J. Gore, and Yorck O. Schumacher
Hemoglobin mass (tHb) is considered to be a main factor for sea-level performance after “live high–train low” (LHTL) altitude training, but little research has focused on the persistence of tHb following cessation of altitude exposure. The aim of the case study was to investigate short-term effects of various hematological measures including tHb upon completion of a simulated altitude camp. Five female cyclists spent 26 nights at simulated altitude (LHTL, 16.6 ± 0.4 h/d, 3000 m in an altitude house) where tHb was measured at baseline, at cessation of the camp, and 9 d thereafter. Venous blood measures (hemoglobin concentration, hematocrit, %reticulocytes, serum erythropoietin, ferritin, lactate dehydrogenase, and haptoglobin) were determined at baseline; on day 21 during LHTL; and at days 2, 5, and 9 after LHTL. Hemoglobin mass increased by 5.5% (90% confidence limits [CL] 2.5 to 8.5%, very likely) after the LHTL training camp. At day 9 after simulated LHTL, tHb decreased by 3.0% (90%CL −5.1 to −1.0%, likely). There was a substantial decrease in serum EPO (−34%, 90%CL −50 to −12%) at 2 d after return to sea level and a rise in ferritin (23%, 90%CL 3 to 46%) coupled with a decrease in %reticulocytes (−23%, 90%CL −34 to −9%) between day 5 and 9 after LHTL. Our findings show that following a hypoxic intervention with a beneficial tHb outcome, there may be a high probability of a rapid tHb decrease upon return to normoxic conditions. This highlights a rapid component in red-cell control and may have implications for the appropriate timing of altitude training in relation to competition.
Avish P. Sharma, Philo U. Saunders, Laura A. Garvican-Lewis, Brad Clark, Marijke Welvaert, Christopher J. Gore, and Kevin G. Thompson
Purpose: To determine the effect of altitude training at 1600 and 1800 m on sea-level (SL) performance in national-level runners. Methods: After 3 wk of SL training, 24 runners completed a 3-wk sojourn at 1600 m (ALT1600, n = 8), 1800 m (ALT1800, n = 9), or SL (CON, n = 7), followed by up to 11 wk of SL racing. Race performance was measured at SL during the lead-in period and repeatedly postintervention. Training volume (in kilometers) and load (session rating of perceived exertion) were calculated for all sessions. Hemoglobin mass was measured via CO rebreathing. Between-groups differences were evaluated using effect sizes (Hedges g). Results: Performance improved in both ALT1600 (mean [SD] 1.5% [0.9%]) and ALT1800 (1.6% [1.3%]) compared with CON (0.4% [1.7%]); g = 0.83 (90% confidence limits −0.10, 1.66) and 0.81 (−0.09, 1.62), respectively. Season-best performances occurred 5 to 71 d postaltitude in ALT1600/1800. There were large increases in training load from lead-in to intervention in ALT1600 (48% [32%]) and ALT1800 (60% [31%]) compared with CON (18% [20%]); g = 1.24 (0.24, 2.08) and 1.69 (0.65, 2.55), respectively. Hemoglobin mass increased in ALT1600 and ALT1800 (∼4%) but not CON. Conclusions: Larger improvements in performance after altitude training may be due to the greater overall load of training in hypoxia compared with normoxia, combined with a hypoxia-mediated increase in hemoglobin mass. A wide time frame for peak performances suggests that the optimal window to race postaltitude is individual, and factors other than altitude exposure per se may be important.
Michael J. Davies, Bradley Clark, Laura A. Garvican-Lewis, Marijke Welvaert, Christopher J. Gore, and Kevin G. Thompson
Purpose: To determine if a series of trials with fraction of inspired oxygen (FiO2) content deception could improve 4000-m cycling time-trial (TT) performance. Methods: A total of 15 trained male cyclists (mean [SD] body mass 74.2 [8.0] kg, peak oxygen uptake 62  mL·kg−1·min−1) completed six 4000-m cycling TTs in a semirandomized order. After a familiarization TT, cyclists were informed in 2 initial trials they were inspiring normoxic air (NORM, FiO2 0.21); however, in 1 trial (deception condition), they inspired hyperoxic air (NORM-DEC, FiO2 0.36). During 2 subsequent TTs, cyclists were informed they were inspiring hyperoxic air (HYPER, FiO2 0.36), but in 1 trial, normoxic air was inspired (HYPER-DEC). In the final TT (NORM-INFORM), the deception was revealed and cyclists were asked to reproduce their best TT performance while inspiring normoxic air. Results: Greater power output and faster performances occurred when cyclists inspired hyperoxic air in both truthful (HYPER) and deceptive (NORM-DEC) trials than NORM (P < .001). However, performance only improved in NORM-INFORM (377 W; 95% confidence interval [CI] 325–429) vs NORM (352 W; 95% CI 299–404; P < .001) when participants (n = 4) completed the trials in the following order: NORM-DEC, NORM, HYPER-DEC, HYPER. Conclusions: Cycling performance improved with acute exposure to hyperoxia. Mechanisms for the improvement were likely physiological; however, improvement in a deception trial suggests an additional placebo effect. Finally, a particular sequence of oxygen deception trials may have built psychophysiological belief in cyclists such that performance improved in a subsequent normoxic trial.